Benzothiazinone vinylidene indene series compound with dibenzothiazinone eight-ring system structure and preparation method of benzothiazinone vinylidene indene series compound

Through the tandem C-H bond activation reaction of palladium and copper catalysts, the benzothiazine vinylidene indene series compounds with dibenzosulfanooctacyclic architecture were successfully constructed, and the synthesis of biaryl dibenzosulfanooctacyclic was solved. The lack of methods has achieved high selectivity and widespread application of compound preparation.

CN118955428APending Publication Date: 2024-11-15ZHEJIANG UNIV CITY COLLEGE
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411003878.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The lack of synthetic methods for biaryl dibenzosulfanoine octacyclic system in the existing technology limits the application scope of such compounds in the fields of medicines and materials.

Method used

Through the combined action of palladium catalyst and copper catalyst, a three-component one-pot reaction was carried out to carry out a highly selective tandem C-H bond activation reaction, and a benzothiazine vinylidene with a dibenzosulfanozooctacyclic architecture was constructed. Indene series compounds.

Benefits of technology

It has achieved a highly selective construction of the octacyclic skeleton structure of the p-dibenzosulfanodium octacyclic framework, simple reaction operation, wide applicability, and compatible with a variety of functional groups, providing potential drug activity and wide application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955428A_ABST
    Figure CN118955428A_ABST
Patent Text Reader

Abstract

According to the method, three components, namely o-bromo aryl imino sulfone propargyl amide, aryl iodobenzene and norbornene, are used as reaction substrate raw materials, and under the catalytic action of a palladium catalyst, a metal catalyst, a ligand and alkali, the reaction substrate raw materials are subjected to a reaction to obtain the benzothiazinone vinylidene indene series compound with the dibenzothiazinone vinylidene indene series compound with the dibenzothiazinone vinylidene indene series compound with the dibenzothiazinone vinylidene indene series structure. The reaction product is a benzothiazinone vinylidene indene series compound with a dibenzothiazinone eight-ring system structure. The method is high in reaction chemical selectivity, wide in substrate applicability and simple and convenient to operate; the method is extremely low in cost, few in by-products and suitable for large-scale preparation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a derivative of a sulfoxide-containing condensed ring drug skeleton, in particular to a benzothiazinone vinylindene series compound having a dibenzothiazine octacyclic system structure and a preparation method thereof. Background Art

[0002] Imidosulfone annular compounds are an important class of heterocyclic compounds with multiple biological activities, which are widely present in natural products and drug molecules. Sulfoximines are widely used in medicine, agrochemicals, chiral precursors and chiral ligands in asymmetric synthesis, as well as key intermediates for the construction of heterocyclic compounds. They are also important scaffolds in many drug molecules and appear more and more frequently in drug synthesis [(a) Org. Lett. 2017, 19, 6020-6023. (b) Angew. Chem. Int. Ed. 2018, 57, 12053–12056. (c) Org. Lett. 2023, 25, 1569-1572]. Since the discovery of sulfoximine in 1949, it has been used as a reagent, chiral ligand, organic catalyst, drug and pesticide in the past few decades. Many sulfoximine-containing molecules, including those invented by Bayer (BAY1000394, BAY1143572) and AstraZeneca (AZD6738), have been found to be biologically active and have been observed to possess high levels of metabolic stability, hydrogen bond acceptor / donor capabilities, and desirable physicochemical properties.

[0003] In recent years, many articles have reported that iminosulfone fused heterocyclic structures can be constructed based on iminosulfone structures [J.Org.Chem.2020,85,15760-15766; Org.Lett.2020,22,8842-8845; Chem.Eur.J.2016,22,10821.], and this type of compound has become an important member of the "toolbox" of medicinal chemists. The cyclin-dependent kinase inhibitor (BAY1000394) developed by Bayer Pharmaceuticals is the first sulfoximine-structured drug molecule to successfully enter clinical research. This structure has also been used in pesticides. Further research on suloxifene isolated the first n-cyanosulfoximine structure. Forty years later, this functional group was used in sulfoximine insecticides, namely the commercially available sulfoximine chloride [J. Agric. Food Chem. 2011, 59, 2950; Science 2011, 67, 328]. In 1970, the sulfoximine structure was shown to be a partial benzodiazepine receptor agonist with excellent anxiolytic and anticonvulsant activity. In addition, the heterocyclic sulfoxide ring was shown to be a potential reverse transcriptase inhibitor with good lymphocyte protection. In fact, studies have shown that the free sulfoximine is a new fragment that may act as a TSM in HIV-1 protease inhibitors. In addition, in cell-based experiments, the free sulfoximine also showed significant antiviral activity. The introduction of n-methyl substituents on the sulfoximine group resulted in a significant reduction in enzyme and antiviral activity. At Bayer Pharmaceuticals, a series of sulfoxide-substituted 1,4-diaryldihydropyrimidine derivatives were identified as selective inhibitors of human neutrophil elastase (HME) for the preparation of drugs for the treatment and prevention of lung diseases and cardiovascular system diseases.

[0004] Existing technologies have synthesis methods for N-aryl dibenzothiazine octacyclic ring systems (Org. Chem. Front., 2019, 6, 3415–3419), but there is no literature report on the synthesis of biaryl dibenzothiazine octacyclic ring systems. Summary of the invention

[0005] In order to expand the synthetic application scope of dibenzothiazolyl octacyclic compounds, the present invention intends to develop a new synthetic method. The present invention uses a compound with a simple structure and is easily available as a raw material. Under the joint action of a palladium catalyst and a copper catalyst, two highly selective tandem CH bond activation reactions occur in a three-component one-pot reaction, and a [8+5] sulfur-nitrogen fused heterocyclic system is highly selectively constructed. The method of the present invention has good compatibility with various functional groups, such as: trifluoromethyl, cyano, chlorine and other sensitive groups, and various heterocyclics, such as: thiophene, naphthalene, pyrrole, can be well compatible, and can construct various sulfur-nitrogen heterocyclic vinylindene series compounds with dibenzothiazolyl octacyclic system skeleton structures. The purpose of the present invention is to provide a preparation method of a benzothiazinone vinylindene series compound with a novel dibenzothiazolyl octacyclic system skeleton structure. The method has simple raw materials, the obtained sulfur-nitrogen octacyclic product has a complex structure, potential pharmaceutical activity, good chemical selectivity of the reaction, wide substrate applicability, simple operation, and is suitable for large-scale preparation.

[0006] A benzothiazinone vinylidene indene series compound having a dibenzothiazine octacyclic system structure, characterized in that:

[0007] Having a structure as shown in Formula IV;

[0008]

[0009] In the formula, R 1 , R 2 , R 3 , R 4 are various substituents; among which R 1 , R 2 , R 3 and R 5 are alkyl, cycloalkyl, or aryl with various electron-donating groups such as alkyl and alkoxy, or aryl with various electron-withdrawing groups such as halogen, cyano, nitro, ester, amide, etc., R 4 It is a cyano group, a nitro group or an ester group.

[0010] A method for preparing a benzothiazinone vinylidene indene series compound having a dibenzothiazine octacyclic system structure is to use o-bromoaryl iminosulfone propargylamide, aryl iodobenzene and norbornene as reaction substrates in an organic solvent, and to obtain a product methyl (Z)-9-(5,9-dimethyl-5-oxidation-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate series compound under the catalytic action of a palladium catalyst, a metal catalyst, a ligand and a base. The general reaction formula is as follows:

[0011]

[0012] Where R 1 , R 2 , R 3 , R 4 are various substituents. 1 , R 2 , R 3 and R 5 are alkyl, cycloalkyl, or aryl with various electron-donating groups such as alkyl and alkoxy, or aryl with various electron-withdrawing groups such as halogen, cyano, nitro, ester, amide, etc., R 4 It is a cyano group, a nitro group or an ester group.

[0013] Wherein, the organic solvent is acetonitrile, 1,4-dioxane, 1,2-dichloroethane, toluene, and tetrahydrofuran.

[0014] The palladium catalyst is palladium acetate, palladium dichloride, tetrakistriphenylphosphine palladium, palladium trifluoroacetate, palladium bromide, and bisacetonitrile palladium dichloride.

[0015] The ligand is a phosphine ligand, and the phosphine ligand is tri(2-furyl)phosphine, 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphine-2'-methylbiphenyl, and 4,5-bis(diphenylphosphine)-9,9-dimethylxanthene.

[0016] The metal catalyst is cuprous bromide, cuprous chloride, cupric acetate, copper trifluoromethanesulfonate, and cuprous trifluoromethanesulfonate.

[0017] The alkaline catalyst is potassium phosphate, potassium carbonate, dipotassium hydrogen phosphate, and pyridine.

[0018] The reaction temperature is controlled at 90-120°C and the reaction time is 10-12h.

[0019] The reaction requires additional inert gas protection as the reaction environment. The inert gas includes nitrogen and argon.

[0020] In the benzothiazinone vinylindene series compound molecules prepared by the above method, the 1-position on the skeleton is an aryl group and an alkyl group. The substituent at the 2-position is various aryl groups with functional groups, pyridine, and thiophene. The substituent at the 3-position is an alkyl group, a halogen atom, a heterocycle, and various electron-withdrawing and electron-donating groups. The substituent at the 4-position is an olefin, an ester group, and a heterocyclic hydrocarbon.

[0021] The beneficial effects of the present invention are: simple reaction mode, simple reaction operation, high chemical selectivity of the reaction, and wide substrate applicability; the reaction product has good compatibility with various groups that have good reaction activity, such as halogens, unsaturated groups, various electron-withdrawing groups and other sensitive groups; after further transformation, more functional groups can be introduced into the product to construct a novel compound with an iminosulfone fused heterocyclic structure, which has very good application prospects in the fields of biomedicine, pesticides and materials science. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 It is a schematic diagram of the single crystal structure of methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate, the product of Example 1 of the present invention.

[0023] Figure 2 It is the chemical structural formula of the product of Example 1 of the present invention, methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate.

[0024] Figure 3 It is the chemical structural formula of a benzothiazinone vinylene indene series compound having a dibenzothiazine octacyclic system structure. DETAILED DESCRIPTION

[0025] The following examples are provided to further illustrate the present invention, but are not intended to limit the scope of the present invention.

[0026] Embodiment 1:

[0027]

[0028] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4a. Yield: 78%. The following is the NMR experimental data of product 4a:

[0029] 1 H NMR (400MHz, CDCl3) δ: 8.26 (d, J = 8.0Hz, 1H), 7.70-7.66 (m, 2H), 7.57-7.54 (m, 2H), 7.49-7. 46(m,3H),7.44-7.41(m,1H),7.22-7.18(m,1H),7.13-7.10(m,2H),3.73(s,3H),3.05-3.00( m,1H),2.77(s,3H),2.70-2.65(m,1H),2.48(s,3H),2.48-2.46(m,1H),2.42-2.35(m,1H),1. 65-1.63(m,1H),1.50-1.42(m,1H),1.31-1.27(m,1H),0.63-0.60(m,1H),0.17-0.14(m,1H).

[0030] 13 C NMR (100MHz, CDCl3) δ: 174.7, 170.6, 149.9, 149.8, 140.6, 139.5, 138.8, 138.1, 136.9, 135.8, 133.4, 132.8, 132. 1,130.7,129.7,129.1,128.7,126.9,126.5,124.8,124.4,51.7,46.8,45.8,44.9,44.7,39.8,33.4,31.1,19.8.

[0031] Embodiment 2:

[0032]

[0033] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72mg, 0.2mmol), palladium dichloride (4.8mg, 0.2mmol), 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl (12.8mg, 0.5mmol), cuprous chloride (5.4mg, 0.4mmol), potassium carbonate (55.2mg, 0.4mmol) were added to the test tube. After N2 replacement 3-4 times, 1,2-dimethyl-3-iodobenzene (69.6mg, 0.3mmol) and methyl 5-norbornene-2-carboxylate (91.4mg, 0.6mmol) were added with a microinjector, and then solvent 1,4-dioxane (2.0mL) was added, and the reaction was carried out at 105°C for 12 hours. TLC detection showed that the reaction was complete. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9,10-trimethyl-5-oxo-7-oxo-5,4-dibenzo[e,g][1,2]thiazepine-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methanofuran-3-carboxylate 4b. Yield: 68%. The following is the NMR experimental data of product 4b:

[0034] 1 H NMR (400MHz, CDCl3) δ: 8.23 ​​(d, J = 8.0Hz, 1H), 7.67-7.63 (m, 2H), 7.53-7.50 (m, 1H), 7.45-7.43 ( m,1H),7.35-7.33(m,2H),7.20-7.16(m,1H),7.12-7.08(m,2H),3.72(s,3H),3.01-3.00(m,1H), 2.76(s,3H),2.68-2.63(m,1H),2.46-2.43(m,1H),2.41(s,3H),2.40(s,3H),2.37-2.36(m,1H) ,1.64-1.63(m,1H),1.49-1.41(m,1H),1.31-1.26(m,1H),0.61-0.58(m,1H),0.13-0.11(m,1H).

[0035] 13C NMR(100MHz, CDCl3)δ:174.7,171.0,149.6,149.2,140.9,139.6,139.5,136.6,136.3,135.5,133.3,132.8,130.5,130.1, 129.7,129.5,128.8,128.8,126.9,126.1,124.5,124.3,51.7,51.6,46.7,45.8,44.9,44.6,39.6,33.4,31.1,20.7,16.4.

[0036] Embodiment three:

[0037]

[0038] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), tetrakistriphenylphosphine palladium (6.4 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), copper trifluoromethanesulfonate (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, 1,3-dimethyl-3-iodobenzene (69.6 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then solvent 1,2-dichloroethane (2.0 mL) was added, and the reaction was carried out at 120°C for 12 hours. TLC detection showed that the reaction was complete. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9,11-trimethyl-5-oxo-7-oxo-5,4-dibenzo[e,g][1,2]thiazepine-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methanofuran-3-carboxylate 4c. Yield: 64%. The following is the NMR experimental data of product 4c:

[0039] 1H NMR(400MHz, CDCl3)δ:8.26-8.23(m,1H),7.69-7.65(m,2H),7.55-7.48(m,2H),7.27-7.2 3(m,2H),7.19-7.17(m,1H),7.13-7.09(m,2H),3.73(s,3H),3.02-3.01(m,1H),2.77(s,3H ),2.69-2.65(m,1H),2.47(s,3H),2.46-2.44(m,1H),2.43(s,3H),2.38-2.37(m,1H),1.65 -1.64(m,1H),1.51-1.43(m,1H),1.34-1.29(m,1H),0.62-0.59(m,1H),0.16-0.14(m,1H).

[0040] 13 C NMR(100MHz, CDCl3)δ:174.8,170.7,149.8,140.8,139.6,138.8,138.5,137.9,135.9,133.9,133.5,133.4,133.1,132.9, 130.6,129.6,129.1,129.0,127.2,127.0,124.7,124.4,51.8,51.7,46.9,45.9,46.0,44.8,39.9,33.5,31.3,21.3,19.8.

[0041] Embodiment 4:

[0042]

[0043] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium bromide (5.6 mg, 0.2 mmol), 2-dicyclohexylphosphine-2'-methylbiphenyl (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, 2-iodo-5-fluorotoluene (70.8 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then tetrahydrofuran (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete after TLC detection. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(11-fluoro-5,9-dimethyl-5-oxo-7-oxo-5,4-dibenzo[e,g][1,2]thiazepine-8(7H)-yl)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methanofuran-3-carboxylate 4c. Yield: 44%. The following is the NMR experimental data of product 4d:

[0044] 1 H NMR(400MHz, CDCl3)δ:8.29-8.27(m,1H),7.70-7.68(m,1H),7.61-7.56(m,1H),7.49-7.47(m,1H),7. 40-7.39(m,2H),7.22-7.20(m,1H),7.18-7.18(m,1H),7.16-7.15(m,1H),7.13-7.13(m,1H),3.74(s, 3H),3.04-3.03(m,1H),2.84(s,3H),2.71-2.66(m,1H),2.48(s,3H),2.45-2.43(m,1H),2.40-2.39(m ,1H),1.59-1.58(m,1H),1.52-1.45(m,1H),1.35-1.29(m,1H),0.62-0.60(m,1H),0.15-0.13(m,1H).

[0045] 13C NMR(100MHz, CDCl3)δ:174.7,170.8,163.3,160.8,150.7,150.0,141.0(d,J =8.0Hz), 140.6 (d, J = 8.0Hz), 137.5, 136.0, 133.6, 133.3, 132.9, 131.1, 130. 0,129.7,128.6(d,J=4.5Hz),128.0,127.1,124.8,124.5,118.8(d,J=10.5Hz ), 113.5 (d, J = 23.0Hz), 51.8, 46.9, 45.9, 45.1, 44.9, 39.9, 33.4, 31.2, 20.1.

[0046] 19 F NMR(376MHz, CDCl3)δ:-113.0(s).

[0047] Embodiment five:

[0048]

[0049] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), 4,5-bis(diphenylphosphine)-9,9-dimethyloxanthene (15.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, 2-iodo-5-chlorotoluene (75.7 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(11-chloro-5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4e. Yield: 36%. The following is the NMR experimental data of the product 4e:

[0050] 1 H NMR(400MHz, CDCl3)δ:8.28-8.26(m,1H),7.70-7.67(m,2H),7.60-7.56(m,1H),

[0051] 7.48-7.44(m,3H),7.23-7.19(m,1H),7.15-7.10(m,2H),3.73(s,3H),3.04-3.02(m,1H),2.85(s,

[0052] 3H),2.72-2.65(m,1H),2.46(s,3H),2.46-2.43(m,1H),2.40-2.38(m,1H),1.56-1.55(m,1H),

[0053] 1.52-1.45(m,1H),1.35-1.28(m,1H),0.61-0.58(m,1H),0.14-0.12(m,1H)

[0054] 13 C NMR(100MHz, CDCl3)δ:174.7,170.7,150.7,150.0,140.5,140.1,139.2,136.0,135.9,134.1,133.7,133.0,131.9,131 .2,130.0,129.7,128.4,127.9,127.1,126.5,124.9,124.5,51.8,51.8,46.9,45.8,45.1,44.9,40.0,33.4,31.3,19.9.

[0055] Embodiment six:

[0056]

[0057] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), bisacetonitrile palladium dichloride (5.8 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added into the test tube. After N2 replacement 3-4 times, 1-iodo-4-methoxy-methylbenzene (74.4 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(11-methoxy-5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4f. Yield: 56%. The following is the NMR experimental data of the product 4f:

[0058] 1 H NMR(400MHz, CDCl3)δ:8.25-8.23(m,1H),7.67-7.64(m,2H),7.56-7.48(m,2H),7.20 -7.16(m,1H),7.12-7.08(m,2H),6.99-6.95(m,2H),3.93(s,3H),3.72(s,3H),3.01-3 .00(m,1H),2.80(s,3H),2.68-2.63(m,1H),2.45(s,4H),2.38-2.37(m,1H),1.65-1.6 4(m,1H),1.51-1.44(m,1H),1.34-1.28(m,1H),0.61-0.59(m,1H),0.15-0.12(m,1H).

[0059] 13 C NMR(100MHz, CDCl3)δ:174.8,170.9,159.3,150.3,149.8,140.4,140.0,139.9,139.6,135.9,133.4,132.7,130.6,129.6, 129.2,129.2,128.8,127.0,124.7,124.4,116.7,112.5,55.5,51.8,51.6,46.8,45.9,45.6,45.0,39.9,33.5,31.3,20.3.

[0060] Embodiment seven:

[0061]

[0062] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, naphthalene iodide (76.2 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain a pure product, methyl (Z)-9-(4-methyl-4-oxido-2-oxo-4l4-benzo[g]naphtho[1,2-e][1,2]thiazosin-1(2H)-ylidene)-2,3,4,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4g. Yield: 49%. The following is the NMR experimental data of the product 4g:

[0063] 1 H NMR(400MHz, CDCl3)δ:8.40-8.32(m,2H),8.09-8.07(m,1H),7.98-7.96(m,1H),7.83-7.81(m ,1H),7.76-7.69(m,2H),7.63-7.60(m,4H),7.27-7.23(m,1H),7.20-7.14(m,2H),3.68(s,3H ),3.01-3.00(m,1H),2.73(s,3H),2.62-2.57(m,1H),2.44-2.42(m,1H),2.37-2.36(m,1H),1 .63-1.62(m,1H),1.39-1.31(m,1H),1.04-1.00(m,1H),0.61-0.58(m,1H),0.21-0.19(m,1H).

[0064] 13C NMR (100MHz, CDCl3) δ: 174.6, 170.8, 150.9, 150.1, 140.6, 139.6, 135.9, 135.3, 135.1, 133.9, 133.4, 132.8, 130.8, 130.6, 129. 9,129.8,129.3,128.4,128.3,128.2,127.8,127.1,125.6,124.9,124.6,51.7,51.5,46.9,45.9,44.9,44.6,39.9,33.4,30.9.

[0065] Embodiment eight:

[0066]

[0067] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous trifluoromethanesulfonate (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, 2-iodoisopropylbenzene (73.8 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(9-isopropyl-5-methyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4h. Yield: 35%. The following is the nuclear magnetic resonance experimental data of the product 4h:

[0068] 1H NMR (400MHz, CDCl3) δ: 8.27 (d, J = 8.0Hz, 1H), 7.69-7.65 (m, 2H), 7.62-7.54 (m, 3H), 7.47-7.41 ( m,2H),7.22-7.18(m,1H),7.15-7.11(m,1H),3.73(s,3H),3.49-3.45(m,1H),3.03-3.01(m,1H), 2.78(s,3H),2.71-2.66(m,1H),2.54-2.52(m,1H),2.41-2.40(m,1H),1.68-1.67(m,1H),1.50- 1.42(m,1H),1.37(d,J=8.0Hz,3H),1.20(d,J=8.0Hz,3H),0.66-0.63(m,1H),0.18-0.16(m,1H).

[0069] 13 C NMR(100MHz, CDCl3)δ:174.6,171.5,150.7,150.0,148.8,141.1,139.6,138.7,135.8,135.7,133.5,132.8,130.6,12 9.7,129.1,128.1,127.0,126.5,124.9,124.4,52.3,51.7,46.9,45.7,45.0,44.6,39.4,33.6,31.4,30.3,25.1,24.0.

[0070] Embodiment nine:

[0071]

[0072] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium dihydrogen phosphate (61.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, 5-iodoquinoline (76.5 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then solvent toluene (2.0 mL) was added, and the reaction was carried out at 90°C for 12 hours. TLC detection showed that the reaction was complete. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(8-methyl-8-oxido-6-oxo-8l4-benzo[7,8][1,2]thiazino[5,6-f]quinoline-5(6H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylic acid 4i. Yield: 27%. The following is the NMR experimental data of product 4i:

[0073] 1 H NMR (400MHz, CDCl3) δ: 9.04 (s, 1H), 8.27 (d, J = 8.0Hz, 1H), 7.69-7.65 (m, 2H), 7.62-7.54 (m, 3H), 7. 47-7.41(m,2H),7.22-7.18(m,1H),7.15-7.11(m,1H),3.73(s,3H),3.49-3.45(m,1H),3.03-3.01( m,1H),2.78(s,3H),2.71-2.66(m,1H),2.54-2.52(m,1H),2.41-2.40(m,1H),1.68-1.67(m,1H),1. 50-1.42(m,1H),1.37(d,J=8.0Hz,3H),1.20(d,J=8.0Hz,3H),0.66-0.63(m,1H),0.18-0.16(m,1H).

[0074] 13C NMR (100MHz, CDCl3) δ: 174.6, 170.8, 151.4, 150.1, 139.8, 139.2, 136.0, 135.9, 135.8, 135.4, 133.7, 133.0, 131. 2,131.1,130.3,129.7,129.3,127.2,127.0,124.8,124.7,51.8,51.5,46.9,45.8,44.8,40.0,33.4,30.9,29.7.

[0075] Embodiment ten:

[0076]

[0077] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (75.3mg, 0.2mmol), palladium dichloride (4.5mg, 0.2mmol), tri(2-furyl)phosphine (11.8mg, 0.5mmol), cuprous chloride (5.6mg, 0.4mmol), pyridine (41.2mg, 0.4mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66mg, 0.3mmol) and methyl 5-norbornene-2-carboxylate (91.4mg, 0.6mmol) were added with a microinjector, and then acetonitrile (2.0mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-6-methyl-2,3,4,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4j. Yield: 28%. The following is the nuclear magnetic resonance experimental data of product 4j:

[0078] 1H NMR (400MHz, CDCl3) δ: 8.26 (d, J = 8.0Hz, 1H), 7.69-7.66 (m, 1H), 7.61-7.54 (m, 2H ),7.49-7.40(m,4H),6.96-6.93(m,2H),3.74(s,3H),2.98-2.96(m,1H),2.77(s,3 H),2.71-2.65(m,1H),2.48(s,3H),2.39-2.38(m,1H),2.31(m,3H),1.17-1.64(m ,1H),1.50-1.42(m,1H),1.30-1.27(m,2H),0.63-0.61(m,1H),0.21-0.18(m,1H).

[0079] 13 C NMR(100MHz, CDCl3)δ:174.8,170.9,150.4,150.3,140.7,140.2,139.0,138.2,137.1,136.9,135.8,133.5,132.8,132.2, 130.7,129.1,128.7,128.2,127.9,126.5,124.9,124.6,52.0,51.8,46.7,45.8,45.0,44.6,39.8,33.5,31.1,21.5,19.9.

[0080] Embodiment eleven:

[0081]

[0082] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (82.5mg, 0.2mmol), palladium acetate (4.5mg, 0.2mmol), tri(2-furyl)phosphine (11.8mg, 0.5mmol), cuprous bromide (5.6mg, 0.4mmol), potassium carbonate (55.2mg, 0.4mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66mg, 0.3mmol) and methyl 5-norbornene-2-carboxylate (91.4mg, 0.6mmol) were added with a microinjector, and then acetonitrile (2.0mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-11-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-6b,8,9,10,10,11-hexahydro-7H-7,10-methoxybenzo[a]fluorene-8-carboxylic acid 4k. Yield: 66%. The following is the NMR experimental data of the product 4k:

[0083] 1 H NMR (400MHz, CDCl3) δ: 8.48 (d, J = 8.0Hz, 1H), 7.78-7.75 (m, 3H), 7.63-7.59 (m, 3H), 7.5 0-7.49(m,3H),7.25-7.20(m,2H),6.60-6.59(m,1H),3.79(s,3H),3.37-3.42(m,1H),2. 79-2.76(m,1H),2.74(s,3H),2.50-2.48(m,1H),2.43-2.42(m,1H),2.39(m,3H),1.77-1 .77(m,1H),1.53-1.46(m,1H),1.32-1.30(m,1H),0.74-0.71(m,1H),0.50-0.47(m,1H).

[0084] 13 C NMR(100MHz, CDCl3)δ:174.8,169.9,151.9,149.0,148.9,141.5,137.9,136.4,136.0,133.8,133.0,132.2,131.9,131.6,131.0,1 29.4,128.6,128.5,126.5,126.2,125.4,123.7,123.5,122.1,111.2,111.1,51.9,51.8,47.9,44.8,44.6,44.1,40.0,33.3,32.2.

[0085] Embodiment 12:

[0086]

[0087] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (86 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-6-(trifluoromethyl)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4l. Yield: 22%. The following is the nuclear magnetic resonance experimental data of the product 4l:

[0088] 1 H NMR(400MHz, CDCl3)δ:8.26(d,J=8.0Hz,1H),7.76-7.68(m,2H),7.60-7.56(m,1H) ,7.50-7.42(m,4H),7.36-7.34(m,2H),3.74(s,3H),3.08-3.07(m,1H),2.78(s,3H) ,2.71-2.65(m,1H),2.52-2.50(m,1H),2.46(s,3H),2.40-2.39(m,1H),1.65-1.64( m,1H),1.51-1.44(m,1H),1.32-1.28(m,1H),0.67-0.64(m,1H),0.13-0.11(m,1H).

[0089] 13C NMR (100MHz, CDCl3) δ: 174.6, 170.1, 150.1, 148.0, 142.9, 140.4, 138.5, 137.9, 136.1, 135.6, 133.7, 133.0, 132.3, 132.0, 131.2 (q, J=3 2Hz), 130.7, 129.4, 129.1, 126.7, 124.9, 124.1, 124.0 (q, J = 270Hz), 121.5, 52.0, 51.8, 46.8, 45.9, 44.8, 44.8, 40.0, 33.5, 31.1, 19.8.

[0090] 19 F NMR(376MHz, CDCl3)δ:-62.5(s).

[0091] Embodiment 13:

[0092]

[0093] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (78 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), copper acetate (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-6,8-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4m. Yield: 64%. The following is the NMR experimental data of the product 4m:

[0094] 1H NMR (400MHz, CDCl3) δ: 8.31 (d, J = 8.0Hz, 1H), 7.74-7.70 (m, 1H), 7.65-7.61 (m, 1H), 7.56-7.54 (m, 1 H),7.47-7.43(m,2H),7.40-7.38(m,1H),6.78-6.76(m,2H),3.74(s,3H),3.10-3.09(m,1H),2.73- 2.68(m,1H),2.63(s,3H),2.38(s,3H),2.36-2.35(m,1H),2.32-2.31(m,1H),2.26(s,3H),2.09(s, 3H),1.70-1.69(m,1H),1.47-1.39(m,1H),1.23-1.19(m,1H),0.74-0.71(m,1H),0.44-0.42(m,1H).

[0095] 13 C NMR(100MHz, CDCl3)δ:174.9,170.5,152.7,150.4,141.3,139.9,138.7,138.6,138.2,136.6,136.1,135.4,133.7,132.2,13 1.4,130.9,130.7,130.4,129.1,128.5,126.4,122.1,51.9,51.8,47.1,45.8,44.5,44.0,39.9,33.5,32.2,23.2,21.3,19.8.

[0096] Embodiment 14:

[0097]

[0098] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (84g, 0.2mol), palladium acetate (4.5g, 0.2mol), tri(2-furyl)phosphine (11.8g, 0.5mol), cuprous bromide (5.6g, 0.4mol), potassium carbonate (55.2g, 0.4mol) were added into the test tube. After N2 replacement 3-4 times, o-iodotoluene (66g, 0.3mol) and methyl 5-norbornene-2-carboxylate (91.4g, 0.6mol) were added with a microinjector, and then acetonitrile (2.0L) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete after TLC detection. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product dimethyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3,6-dicarboxylate 4n. Yield: 48%. The following is the NMR experimental data of the product 4n:

[0099] 1 H NMR(400MHz, CDCl3)δ:8.27(d,J=8.0Hz,1H),7.79-7.78(m,2H),7.73-7.68(m,2H),7.59-7.55 (m,1H),7.50-7.48(m,2H),7.45-7.43(m,1H),7.32(s,1H),3.91(s,3H),3.75(s,3H),3.08-3. 06(m,1H),2.79(s,3H),2.72-2.67(m,1H),2.53-2.52(m,1H),2.48(s,3H),2.44-2.43(m,1H), 1.65-1.64(m,1H),1.50-1.44(m,1H),1.34-1.30(m,1H),0.66-0.63(m,1H),0.11-0.10(m,1H).

[0100] 13 C NMR(100MHz, CDCl3)δ:174.6,170.1,166.8,149.9,148.4,144.0,140.4,138.6,137.9,136.4,135.7,133.7,133.0,132.3,132 .1,130.9,130.7,129.3,129.0,128.4,126.7,125.8,124.5,52.1,52.0,51.9,46.7,45.9,44.9,44.8,40.0,33.5,31.2,19.8.

[0101] Embodiment 15:

[0102]

[0103] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (88g, 0.2mol), palladium acetate (4.5g, 0.2mol), tri(2-furyl)phosphine (11.8g, 0.5mol), cuprous bromide (5.6g, 0.4mol), potassium carbonate (55.2g, 0.4mol) were added into the test tube. After N2 replacement 3-4 times, o-iodotoluene (66g, 0.3mol) and methyl 5-norbornene-2-carboxylate (91.4g, 0.6mol) were added with a microinjector, and then acetonitrile (2.0L) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete after TLC detection. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-7-phenyl-2,3,4,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4o. Yield: 37%. The following is the NMR experimental data of the product 4o:

[0104] 1 H NMR (400MHz, CDCl3) δ: 8.25 (d, J = 8.0Hz, 1H), 7.94 (s, 1H), 7.69-7.66 (m, 2H), 7.60-7.52 (m ,3H),7.50-7.41(m,7H),7.36-7.32(m,1H),7.20-7.18(m,1H),3.75(s,3H),3.06-3.05(m,1 H),2.77(s,3H),2.72-2.67(m,1H),2.52-2.50(m,1H),2.50(s,3H),2.44-2.43(m,1H),1.6 7-1.66(m,1H),1.51-1.47(m,1H),1.32-1.30(m,1H),0.66-0.63(m,1H),0.28-0.25(m,1H).

[0105] 13C NMR(100MHz, CDCl3)δ:174.8,170.8,150.2,149.2,140.9,140.7,140.2,140.0,138.9,138.0,137.2,136.0,133.5,133.0,132.2, 130.9,129.5,129.2,128.8,128.7,127.5,127.1,126.7,124.7,123.4,52.2,51.8,46.6,45.9,45.0,44.8,40.0,33.6,31.2,19.9.

[0106] Embodiment 16:

[0107]

[0108] Under air atmosphere, o-bromoiminosulfone reagent (81.2 g) containing alkynyl aromatic group, palladium acetate (4.5 g), tri(2-furyl)phosphine (11.8 g), copper trifluoromethanesulfonate (6.8 g), potassium phosphate (65.2 g) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 g) and methyl 5-norbornene-2-carboxylate (91.4 g) were added using a microinjector, and then solvent 1,4-dioxane (2.0 L) was added, and the reaction was carried out at 90°C for 12 hours. The reaction was complete after TLC detection. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-4b,6,7,8,8a,9-hexahydro-5H-5,8-methylfluoro[2,3-d][1,3]dioxane-6-carboxylate 4p. Yield: 34%. The following is the NMR experimental data of the product 4p:

[0109] 11H NMR (400 MHz, CDCl3) δ: 8.26 (d, J = 8.0 Hz, 1H), 7.69 - 7.65 (m, 1H), 7.58 - 7.56 (m, 1H), 7.48 - 7.40 (m, 4H), 7.28 - 7.26 (m, 1H), 6.66 - 6.63 (m, 1H), 5.94 (s, 1H), 5.90 (s, 1H), 3.72 (s, 3H), 3.06 - 3.05 (m, 1H), 2.75 (s, 3H), 2.69 - 2.64 (m, 1H), 2.58 - 2.55 (m, 1H), 2.47 (s, 3H), 2.47 - 2.44 (m, 1H), 1.63 - 1.62 (m, 1H), 1.48 - 1.41 (m, 1H), 1.28 - 1.26 (m, 1H), 0.67 - 0.62 (m, 1H), 0.25 - 0.23 (m, 1H).

[0110] 13 13C NMR (100 MHz, CDCl3) δ: 174.7, 171.0, 149.4, 148.6, 142.6, 140.7, 139.0, 138.2, 137.1, 135.9, 134.8, 133.5, 132.9, 132.2, 130.7, 130.3, 129.1, 128.7, 126.6, 118.9, 108.1, 101.4, 52.8, 52.7, 51.8, 44.8, 44.7, 43.4, 43.2, 39.9, 33.8, 31.1, 19.9.

[0111] Example XVII:

[0112]

[0113] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (73.6 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-8-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-3b,5,6,7,7a,8-hexahydro-4H-4,7-carboxamidino[2,1-b]thiophene-5-carboxylate 4q. Yield: 52%. The following is the NMR experimental data of the product 4q:

[0114] 1 H NMR (400MHz, CDCl3) δ: 8.19 (d, J = 8.0Hz, 1H), 7.68-7.64 (m, 1H), 7.56-7.53 (m, 2H), 7 .44-7.35(m,3H),7.20((d,J=8.0Hz,1H),6.82((d,J=4.0Hz,1H),3.73(s,3H),2.99-2 .96(m,2H),2.75-2.71(m,1H),2.69(s,3H),2.46-2.45(m,1H),2.35(s,3H),1.88-1.8 7(m,1H),1.57-1.49(m,1H),1.28-1.25(m,1H),0.64-0.81(m,1H),0.70-0.68(m,1H).

[0115] 13 C NMR(100MHz, CDCl3)δ:174.7,174.3,161.0,155.9,143.1,141.8,139.7,139.4,137.8,136.7,136.3,133.7,132 .0,131.5,131.0,128.9,127.4,127.4,122.3,121.1,59.6,51.2,45.0,44.2,43.4,42.9,39.9,33.3,31.1,20.5.

[0116] Embodiment 18:

[0117]

[0118] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (84.9 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4r. Yield: 58%. The following is the nuclear magnetic resonance experimental data of the product 4r:

[0119] 1 H NMR(400MHz, CDCl3)δ:8.48(d,J=8.0Hz,1H),7.81(d,J=8.0Hz,1H),7.60-7.52(m,2H),7.42-7.35(m ,2H),7.26-7.25(m,1H),7.21-7.17(m,3H),7.15-7.10(m,4H),7.08-7.06(m,1H),6.56(d,J=8.0Hz,1 H),3.72(s,3H),3.03-3.01(m,1H),2.67-2.63(m,1H),2.51(s,3H),2.47-2.45(m,1H),2.39-2.38(m ,1H),1.67-1.65(m,1H),1.45-1.38(m,1H),1.27-1.23(m,1H),0.63-0.60(m,1H),0.19-0.16(m,1H).

[0120] 13C NMR(100MHz, CDCl3)δ:174.8,171.6,151.1,150.1,141.2,139.6,139.4,139.2,137.2,137.0,136.8,133.3,132.9,132.4,131.5,1 30.5,129.8,129.4,128.8,128.5,128.3,127.5,127.0,126.6,125.1,124.5,52.0,51.8,46.9,45.9,45.0,39.7,33.5,31.2,19.9.

[0121] Embodiment 19:

[0122]

[0123] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (90.6mg, 0.2mmol), palladium acetate (4.5mg, 0.2mmol), tri(2-furyl)phosphine (11.8mg, 0.5mmol), cuprous bromide (5.6mg, 0.4mmol), potassium carbonate (55.2mg, 0.4mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66mg, 0.3mmol) and methyl 5-norbornene-2-carboxylate (91.4mg, 0.6mmol) were added with a microinjector, and then acetonitrile (2.0mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-6-methoxy-9-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4s. Yield: 52%. The following is the NMR experimental data of the product 4s:

[0124] 1H NMR(400MHz, CDCl3)δ:8.47(d,J=8.0Hz,1H),7.82(d,J=8.0Hz,1H),7.60-7.53(m,2H),7.42-7.35(m,2H),7.26-7.24 (m,1H),7.21-7.17(m,2H),7.13-7.09(m,2H),7.07-7.04(m,1H),6.74-6.71(m,1H),6.59(s,1H),6.54(d,J=8.0Hz,1 H),3.79(s,3H),3.73(s,3H),3.64-3.61(m,1H),2.99-2.97(m,1H),2.69-2.64(m,1H),2.50(s,3H),2.47-2.45(m,1H ),2.39-2.38(m,1H),1.68-1.67(m,1H),1.45-1.39(m,1H),1.25-1.20(m,1H),0.65-0.63(m,1H),0.27-0.24(m,1H).

[0125] 13 C NMR(100MHz, CDCl3)δ:174.8,172.1,161.4,152.7,152.0,141.4,139.4,137.5,137.2,137.1,133.2,132.8,132.6,132.2,131 .4,130.5,128.7,128.5,128.1,127.6,126.7,126.6,113.9,108.5,55.5,52.8,51.8,46.9,45.7,44.9,39.7,33.5,31.2,19.9.

[0126] Embodiment 20:

[0127]

[0128] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (87.7 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-6-methyl-9-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazine-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4t. Yield: 68%. The following is the nuclear magnetic resonance experimental data of the product 4t:

[0129] 1 H NMR(400MHz, CDCl3)δ:8.61(d,J=8.0Hz,1H),7.86(d,J=8.0Hz,1H),7.71-7.67(m,2H),7.53-7.48(m,2 H),7.43-7.38(m,2H),7.32-7.31(m,2H),7.26-7.24(m,2H),7.11-7.06(m,2H),6.68(d,J=8.0Hz,1H), 3.86(s,3H),3.10-3.10(m,1H),2.78-2.69(m,1H),2.64(s,3H),2.64-2.58(m,1H),2.58-2.51(m,1H), 2.44(s,3H),1.79(s,1H),1.54-1.52(m,1H),1.42-1.36(m,1H),0.67-0.74(m,1H),0.35-0.33(m,1H).

[0130] 13C NMR(100MHz, CDCl3)δ:174.8,171.7,151.5,150.6,141.3,140.3,139.4,139.3,137.2,137.1,133.3,132.9,132.4,131.4, 130.5,128.8,128.5,128.2,128.1,127.5,126.6,124.9,124.8,52.3,51.8,46.7,45.8,45.0,39.7,33.5,31.2,21.5,19.9.

[0131] Embodiment 21:

[0132]

[0133] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (90 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-6-cyano-9-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2,3,4,4a,9,9-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4u. Yield: 25%. The following is the NMR experimental data of the product 4u:

[0134] 1H NMR(400MHz, CDCl3)δ:8.50(d,J=8.0Hz,1H),7.87(d,J=8.0Hz,1H),7.63-7.60(m,2H),7.44- 7.42(m,3H),7.39-7.37(m,1H),7.29-7.27(m,1H),7.24-7.20(m,2H),7.14-7.09(m,3H),6.5 9(d,J=8.0Hz,1H),3.74(s,3H),3.09-3.07(m,1H),2.72-2.66(m,1H),2.51(s,3H),2.39-2.3 8(m,1H),1.68(s,2H),1.49-1.42(m,1H),1.29(s,1H),0.70-0.67(m,1H),0.13-0.10(m,1H).

[0135] 13 C NMR(100MHz, CDCl3)δ:174.5,170.7,150.4,148.4,144.1,140.9,139.1,138.7,136.9,135.8,133.7,133.5,133.2,132.6,131.7,1 30.7,130.6,129.1,128.8,128.7,128.4,127.3,126.6,125.5,118.9,112.6,51.0,51.9,46.7,45.9,44.8,39.9,33.6,31.1,19.8.

[0136] Embodiment 22:

[0137]

[0138] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (98.5mg, 0.2mmol), palladium acetate (4.5mg, 0.2mmol), tri(2-furyl)phosphine (11.8mg, 0.5mmol), cuprous bromide (5.6mg, 0.4mmol), potassium carbonate (55.2mg, 0.4mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66mg, 0.3mmol) and methyl 5-norbornene-2-carboxylate (91.4mg, 0.6mmol) were added with a microinjector, and then acetonitrile (2.0mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-9-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-6-(trifluoromethyl)-2,3,4,4a,9,9a-hexahydro-1H-1,4-methylfluorene-3-carboxylate 4v. Yield: 50%. The following is the nuclear magnetic resonance experimental data of the product 4v:

[0139] 1 H NMR(400MHz, CDCl3)δ:8.48(d,J=8.0Hz,1H),7.88(d,J=8.0Hz,1H),7.61-7.55(m,2H),7.43 -7.36(m,4H),7.28-7.26(m,1H),7.22-7.18(m,2H),7.12-7.07(m,3H),6.57(d,J=8.0Hz,1H) ,3.73(s,3H),3.09-3.07(m,1H),2.70-2.65(m,1H),2.52-2.50(m,4H),2.40-2.39(m,1H),1. 68-1.67(m,1H),1.48-1.40(m,1H),1.27-1.23(m,1H),0.68-0.65(m,1H),0.15-0.13(m,1H).

[0140] 13C NMR(100MHz, CDCl3)δ:174.6,171.0,150.3,149.0,143.0,140.9,139.2,138.8,136.9,136.8,136.0,133.5,133.1,132.5,132.3,131.6,130.5, 129.0,128.7,128.6,127.3,126.8(q,J=271Hz),126.6,125.2,124.1,12 4.0,121.5,121.4,52.1,51.9,46.8,45.9,44.8,39.8,33.6,31.1,19.7.

[0141] 19 FNMR(376MHz, CDCl3)δ:-62.5(s).

[0142] Embodiment 23:

[0143]

[0144] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (86 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and methyl 5-norbornene-2-carboxylate (91.4 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product methyl (Z)-8-(9-methyl-5-oxido-7-oxo-5-phenyl-5l4-dibenzo[e,g][1,2]thiazosin-8(7H)-ylidene)-3b,5,6,7,7a,8-hexahydro-4H-4,7-carboxamidino[2,1-b]thiophene-5-carboxylate 4w. Yield: 38%. The following is the nuclear magnetic resonance experimental data of the product 4w:

[0145] 1H NMR (400MHz, CDCl3) δ: 8.40 (d, J = 8.0Hz, 1H), 7.58-7.52 (m, 4H), 7.43-7.39 (m, 2H ),7.21-7.18(m,2H),7.15-7.12(m,2H),7.10-7.09(m,1H),6.85(d,J=4.0Hz,1H), 6.49(d,J=8.0Hz,1H),3.73(s,3H),3.00-2.98(m,2H),2.76-2.71(m,1H),2.45(s ,3H),1.88-1.87(m,1H),1.53-1.46(m,1H),1.30-1.23(m,2H),0.84-0.72(m,2H).

[0146] 13 C NMR(100MHz, CDCl3)δ:174.8,174.4,161.1,156.3,143.3,141.9,139.9,139.3,138.7,138.2,138.0,136.0,133.4,132.8,1 31.9,131.0,130.7,128.8,128.6,128.4,128.0,127.2,122.4,121.2,59.6,51.9,45.0,44.2,42.9,39.9,33.4,31.1,20.5.

[0147] Embodiment 24:

[0148]

[0149] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and norbornadiene (55.3 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product (Z)-5,9-dimethyl-8-(1,4,4a,9a-tetrahydro-9H-1,4-methylfluorene-9-ylidene)-5l4-dibenzo[e,g][1,2]thiazin-7(8H)-one 5-oxide 4x. Yield: 11%. The following is the nuclear magnetic resonance experimental data of the product 4x:

[0150] 1 H NMR (400MHz, CDCl3) δ: 8.24 (d, J = 8.0Hz, 1H), 7.68-7.62 (m, 2H), 7.54-7.52 (m,2H),7.48-7.45(m,3H),7.18-7.08(m,3H),6.15-6.12(m,1H),5.77-5.1 5(m,1H),3.05-2.03(m,1H),2.76(s,3H),2.61-2.60(m,1H),2.45(s,3H),2 .43-2.42(m,1H),2.16-2.14(m,1H),0.73-0.71(m,1H),0.10-0.08(m,1H).

[0151] 13 C NMR(100MHz, CDCl3)δ:170.9,148.2,140.9,140.5,139.0,138.1,137.2,136.9,135.5,133.7,132.9 ,132.1,130.6,129.6,129.2,128.8,127.0,126.6,125.2,124.3,50.6,49.3,47.6,44.7,41.5,19.8.

[0152] Embodiment 25:

[0153]

[0154] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added to the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and norbornene (56.5 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete when detected by TLC. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product (Z)-8-(1,2,3,4,4a,9a-hexahydro-9H-1,4-methylfluorene-9-ylidene)-5,9-dimethyl-5l4-dibenzo[e,g][1,2]thiazin-7(8H)-one 5-oxide 4y. Yield: 32%. The following is the NMR experimental data of the product 4y:

[0155] 1 H NMR (400MHz, CDCl3) δ: 8.27 (d, J = 8.0Hz, 1H), 7.69-7.65 (m, 2H), 7.57-7.53 (m, 1H), 7 .50-7.48(m,1H),7.46-7.42(m,3H),7.19-7.18(m,1H),7.13-7.09(m,2H),2.96-2.9 5(m,1H),2.77(s,3H),2.48(s,3H),2.37-2.35(m,1H),2.07-2.06(m,1H),1.59-1.58 (m,1H),1.46-1.39(m,1H),1.29-1.22(m,3H),0.82-0.70(m,1H),0.46-0.43(m,1H).

[0156] 13 C NMR(100MHz, CDCl3)δ:170.9,150.9,150.9,140.7,139.3,139.1,138.0,137.2,135.8,133.5,132.9,132.0,1 30.6,129.7,129.1,128.6,126.7,126.6,127.8,124.5,52.3,52.0,44.7,42.4,39.3,31.9,28.8,28.3,19.9.

[0157] Embodiment 26:

[0158]

[0159] Under air atmosphere, o-bromoiminosulfone reagent containing alkynyl aromatic group (72 mg, 0.2 mmol), palladium acetate (4.5 mg, 0.2 mmol), tri(2-furyl)phosphine (11.8 mg, 0.5 mmol), cuprous bromide (5.6 mg, 0.4 mmol), potassium carbonate (55.2 mg, 0.4 mmol) were added into the test tube. After N2 replacement 3-4 times, o-iodotoluene (66 mg, 0.3 mmol) and 2-(4-methylphenyl)-3a,4,7,7a-tetrahydro-1H-4,7-formylisoindole-1,3(2H)-dione (152 mg, 0.6 mmol) were added with a microinjector, and then acetonitrile (2.0 mL) was added as solvent, and the reaction was carried out at 90°C for 12 hours. The reaction was complete after TLC detection. During post-treatment, other impurities were first removed by suction filtration through a sand core funnel filled with silica gel, and the resulting filtrate was separated by rapid column chromatography to obtain the pure product (Z)-9-(5,9-dimethyl-5-oxido-7-oxo-5l4-dibenzo[e,g][1,2]thiazolyl-8(7H)-ylidene)-2-(p-tolyl)-4,4a,9,9a,10,10-hexahydro-4,10-carboxamidino[1,2-f]isoindole-1,3(2H,3aH)-dione 4z. Yield: 45%. The following is the NMR experimental data of the product 4z:

[0160] 1 H NMR (400MHz, CDCl3) δ: 8.29 (d, J = 8.0Hz, 1H), 7.74-7.68 (m, 2H), 7.61-7.57 (m, 2 H),7.53-7.45(m,3H),7.30-7.22(m,4H),7.18-7.14(m,2H),6.99(d,J=8.0Hz,1H ),3.24-3.16(m,2H),2.98-2.94(m,1H),2.79(s,3H),2.72-2.71(m,1H),2.66-2. 64(m,1H),2.40(s,6H),2.15-2.14(m,1H),0.96-0.94(m,1H),0.49-0.46(m,1H).

[0161] 13C NMR(100MHz,CDCl3)δ:176.8,175.8,170.2,148.5,148.4,140.7,139.2,139.0,138.5,137.8,135.9,135.8,133.7,132.8,132.6,130.8,130.3,130.3,130.0,129.3,129.2,129.1,127.5,126.8,126.3,124.9,124.6,47.7,47.5,46.9,46.9,45.0,44.7,42.4,35.7,21.2,19.7。

Claims

1. A benzothiazinone vinylidene indene series compound having a dibenzothiazine octacyclic system structure, characterized in that: Having a structure as shown in Formula IV; In the formula, R 1 , R 2 , R 3 , R 4 are various substituents; R 1 , R 2 , R 3 and R 5 are alkyl, cycloalkyl, or aryl with various electron-donating groups such as alkyl and alkoxy, or aryl with various electron-withdrawing groups such as halogen, cyano, nitro, ester, amide, etc., R 4 It is a cyano group, a nitro group or an ester group.

2. The method for preparing a benzothiazinone vinylidene indene series compound having a dibenzothiazine octacyclic system structure according to claim 1, comprising the following steps: In an organic solvent, an o-bromoaryl iminosulfone propargyl amide of a structure such as formula I, an aryl iodobenzene of a structure such as formula II, and a norbornene or norbornadiene of a structure such as formula III are used as reaction substrates, and a product of a structure such as formula IV is reacted under the catalytic action of a palladium catalyst, a metal catalyst, a ligand and a base to form a benzothiazinone vinylindene series compound having a dibenzothiazine octacyclic system structure; Where R 1 , R 2 , R 3 , R 4 are various substituents; R 1 , R 2 , R 3 and R 5 are alkyl, cycloalkyl, or aryl with various electron-donating groups such as alkyl and alkoxy, or aryl with various electron-withdrawing groups such as halogen, cyano, nitro, ester, amide, etc., R 4 It is a cyano group, a nitro group or an ester group.

3. The method according to claim 2, characterized in that The palladium catalyst is palladium acetate, palladium dichloride, tetrakistriphenylphosphine palladium, palladium trifluoroacetate, palladium bromide, bisacetonitrile palladium dichloride.

4. The method according to claim 2, characterized in that: The metal catalyst is cuprous bromide, cuprous chloride, cupric acetate, copper trifluoromethanesulfonate, or cuprous trifluoromethanesulfonate.

5. The method according to claim 2, characterized in that: The ligand is a phosphine ligand, and the phosphine ligand is tri(difuranyl)phosphine, 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphine-2'-methylbiphenyl, and 4,5-bis(diphenylphosphine)-9,9-dimethylxanthene.

6. The method according to claim 2, characterized in that The organic mixed solvent is acetonitrile, 1,4-dioxane, 1,2-dichloroethane, toluene and tetrahydrofuran.

7. The method according to claim 2, characterized in that The alkaline catalyst is potassium phosphate, potassium carbonate, dipotassium hydrogen phosphate, and pyridine.

8. The method according to claim 2, characterized in that: The reaction temperature is 90-120° C. and the reaction time is 10-12 hours.

9. The method according to claim 2, characterized in that: The reaction is carried out under an inert gas environment.

Citation Information

Cited By

  • Application of benzothiazinone vinylidene indene compound in preparation of medicine for inhibiting osteoclast differentiation

    CN120267652A

  • Application of benzothiazinone vinylidene indene compounds in the preparation of drugs for inhibiting osteoclast differentiation

    CN120267652B